Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen
- PMID: 82581
Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen
Abstract
In the accompanying report, we have described the characterization of two unusual murine B cell lymphomas, CH1 and CH2. A heterologous antiserum, which we refer to as "anti-idiotype" serum, has been raised to the detergent-solubilized surface immunoglobulin of CH1. The following criteria have established that this antiserum is specific for the CH1 tumor and that it reacts with V region determinants of the tumor surface IgM: 1) the antiserum reacts with CH1 tumor cells, but not normal mouse lymphoid cells or CH2 tumor cells, in indirect immunofluorescence and C-dependent cytotoxicity testing, 2) capping with the anti-idiotype serum removes all or most of the tumor surface Ig, 3) the antiserum forms a single band of precipitation against serum from CH1 tumor-bearing mice, when tested by double diffusion precipitin analysis, and 4) a single band of precipitation is formed in the electrophoretic migration position of IgM when the anti-idiotype antiserum is tested against serum from CH1 tumor-bearing mice in immunoelectrophoresis. Furthermore, we have demonstrated that this antiserum is useful in monitoring tumor growth and is a potent immunotherapeutic agent. Specifically, 50% of mice injected with a lethal tumor inoculum and given a small dose of anti-idiotype serum 2 days later remain tumor free, whereas all tumor-challenged control mice died within 30 days.
Similar articles
-
Xenoantisera against a murine T cell tumor product cross-react with immunoglobulin Fab determinants.J Immunol. 1983 Sep;131(3):1582-90. J Immunol. 1983. PMID: 6350458
-
Antigen-induced lymphomagenesis: identification of a murine B cell lymphoma with known antigen specificity.J Immunol. 1983 Oct;131(4):2064-8. J Immunol. 1983. PMID: 6194226
-
Characterization of the spontaneous murine B cell leukemia (BCL1). III. Evidence for monoclonality by using an anti-idiotype antibody.J Immunol. 1979 May;122(5):1649-54. J Immunol. 1979. PMID: 109513
-
Antigen-specific B cell tumors of mice.Crit Rev Immunol. 1986;6(2):105-21. Crit Rev Immunol. 1986. PMID: 3524998 Review.
-
BCL1, a murine model for chronic lymphocytic leukemia: use of the surface immunoglobulin idiotype for the detection and treatment of tumor.Immunol Rev. 1979;48:81-106. doi: 10.1111/j.1600-065x.1979.tb00299.x. Immunol Rev. 1979. PMID: 94899 Review. No abstract available.
Cited by
-
Diversity of immunoglobulin lambda light chain gene usage over developmental stages in the horse.Dev Comp Immunol. 2014 Oct;46(2):171-9. doi: 10.1016/j.dci.2014.04.001. Epub 2014 Apr 12. Dev Comp Immunol. 2014. PMID: 24726757 Free PMC article.
-
Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces.Br J Cancer. 1980 Oct;42(4):495-502. doi: 10.1038/bjc.1980.271. Br J Cancer. 1980. PMID: 7192154 Free PMC article.
-
Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens.J Exp Med. 1985 Jul 1;162(1):19-34. doi: 10.1084/jem.162.1.19. J Exp Med. 1985. PMID: 3925067 Free PMC article. Review.
-
Treatment of lymphoid tumors with anti-idiotype antibodies.Springer Semin Immunopathol. 1983;6(1):99-115. doi: 10.1007/BF01857369. Springer Semin Immunopathol. 1983. PMID: 6351310 Review. No abstract available.
-
Immunotherapy of B lymphoma by anti-idiotype antibodies: characterization of variant tumour cells appearing a long time after the initial tumour inoculation.Cancer Immunol Immunother. 1991;34(1):43-8. doi: 10.1007/BF01741323. Cancer Immunol Immunother. 1991. PMID: 1760810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources